Home » Topics » Regulatory » Patents

Patents
RSS

Bristol Myers Squibb patents diacylglycerol kinase alpha/zeta inhibitors

July 28, 2021

Dual GCGR and GLP-1 agonists patented by Merck & Co.

July 28, 2021

Medshine Discovery discovers ketohexokinase inhibitors

July 28, 2021

Jiangsu Simcere Pharmaceutical R&D describes TGF-beta receptor type-1 inhibitors

July 27, 2021

New DGAT-2 inhibitors discovered at LG Chem

July 27, 2021

Beijing Scitech-Mq Pharmaceuticals identifies new FGFR4 inhibitors

July 27, 2021

Japan Tobacco divulges new NLRP3 inflammasome inhibitors

July 27, 2021

New glucagon-like peptide 1 derivatives identified at Gan & Lee Pharmaceuticals

July 26, 2021

Multiple kinase inhibitors identified at Medshine Discovery

July 26, 2021

Sunshine Lake Pharma, Dongguan Hec New Drug Research and Development patent RORgammaT antagonists

July 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...